TITLE

Research Capsules

PUB. DATE
May 2008
SOURCE
Pharmaceutical Representative;May2008, Vol. 38 Issue 5, p13
SOURCE TYPE
Periodical
DOC. TYPE
Product Review
ABSTRACT
The article evaluates Actemra, from Roche.
ACCESSION #
31900664

 

Related Articles

  • Roche emphasizes preparedness for flu season.  // Pharmacy Today;Nov2008, Vol. 14 Issue 11, p1 

    The article evaluates the Tamiflu (oseltamivir) from Roche AG.

  • TYPICAL ENTRY.  // MPR - Pharmacist's Edition;Winter2014/2015, Vol. 8 Issue 4, pA12 

    The article offers information on the Demadex diuretic tablet from F. Hoffmann-La Roche Ltd.

  • MUSCULOSKELETAL DISORDERS.  // MPR - Pharmacist's Edition;Winter2014/2015, Vol. 8 Issue 4, p131 

    The article offers brief information on several drugs for musculoskeletal disorders which includes Actemra from Genentech Inc., Aleve from Bayer Consumer Care AG, and Anaprox from F. Hoffman-La Roche Ltd.

  • SNDA FILED FOR XENICAL AS TYPE 2 DIABETES TREATMENT OPTION.  // Worldwide Biotech;May2001, Vol. 13 Issue 5, p3 

    Reports that Roche has announced that a supplemental New Drug Application has been submitted to the United States Food and Drug Administration for Xenical.

  • Roche moves OTC work in central Europe to Saatchi.  // Advertising Age's Euromarketing;8/6/96, Vol. 9 Issue 47, p1 

    Reports that Roche Consumer Health of eastern Europe has awarded Saatchi & Saatchi the advertising accounts for its Supradyn, Rennie, Aspro and Bepanthene brands. Value of the account.

  • Roche invests in proteomics programme.  // Life Science Today;Dec2000, Vol. 1 Issue 6, p7 

    Focuses on the total amount of money allotted by Roche to link proteomics research in the pharmaceuticals and diagnostics division of the company in Switzerland. Description of proteomics; Accounts on the gene function in the post-genomic era; Identification of the protein used as potential...

  • Roche. Valdmanis, Thor // Financial World;5/20/96, Vol. 165 Issue 8, p24 

    Features Swiss drugmaker Roche. Merger of Roche's rivals Sandoz and Ciba-Geigy; Displacement of Roche as a Switzerland's top pharmaceutical concern; Growing trend towards large pharmaceutical companies worldwide.

  • No sale.  // WWD: Women's Wear Daily;2/7/1997, Vol. 173 Issue 26, p10 

    Reports on the impact of Roche Holdings Ltd.'s announcement to acquire a United States-based flavors business on speculations about the sale of Givaudan-Roure, its fragrance flavors division.

  • Roche rush.  // njbiz;7/2/2012, Vol. 25 Issue 27, p11 

    The article contends that to say that the decision of pharmaceutical company Roche to close its Nutley, New Jersey, operation came as a shock would be an understatement.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics